“Over the past year, we have taken important steps in our commercial development and laid the foundation for our next growth phase. With her experience from international operations, Ida Nordberg brings expertise that will be valuable as we continue building for long-term growth and take the next step in the company’s development,” says Karin Granath, CEO of PeptiSystems.

Ida Nordberg

Nordberg has more than 15 years of experience in financial roles within the life science industry. She joins PeptiSystems from Oncopeptides and has previously held positions at GE Healthcare and C-RAD, where she gained broad experience in financial management, reporting, and business support in international operations.

“PeptiSystems is in an exciting phase with strong commercial momentum. I look forward to contributing with my experience as the company continues to grow and strengthen its position in the market,” says Nordberg.